Methodist Estabrook Cancer Center — Omaha, Nebraska

Methodist Estabrook Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Methodist Estabrook Cancer Center has participated in 65 clinical trials with 5 currently active.

Therapeutic areas: Breast Cancer, Lymphoma, Ovarian Cancer.

Sponsors: NSABP Foundation Inc, Eastern Cooperative Oncology Group, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Methodist Estabrook Cancer Center?

Methodist Estabrook Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Methodist Estabrook Cancer Center conducted?

Methodist Estabrook Cancer Center has 65 clinical trials on record, with 5 currently active. Their work covers Breast Cancer, Lymphoma, Ovarian Cancer.

Is Methodist Estabrook Cancer Center accredited by Crixeo Health?

Methodist Estabrook Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Methodist Estabrook Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.